Life Science Investing LEQEMBI® IQLIK Subcutaneous Autoinjector Named to TIME's "Best Inventions of 2025" 13 October
Life Science Investing LEQEMBI® IQLIK Subcutaneous Autoinjector Named to TIME's "Best Inventions of 2025" 13 October
Life Science Investing Eisai and Biogen Announce U.S. Availability of LEQEMBI® IQLIK Subcutaneous Injection Maintenance Dose for Treatment of Early Alzheimer's Disease 06 October
